Statistics
Publications
3
Citations
105
H-Index
3
Active since
2023
Qibiao Wu is an author at Broad Institute specializing in oncology, kinase mutation-mediated resistance, and reversible tyrosine kinase inhibitors.
Publications per year
2023–2025
3
3
The Irreversible FGFR Inhibitor KIN-3248 Overcomes FGFR2 Kinase Domain Mutations
Eranga R. Balasooriya, Qibiao Wu, Haley Ellis et al. · Clinical Cancer Research · 2024 · 16 citations · Full text
Medicine, Oncology, Pharmacology +17
1–3 of 3